Testicular function in the dog was down-regulated using two different GNRH agonist implants, with adult and juvenile testes serving as controls. Treatment resulted in an increased percentage of the interstitial area and decreased area of Leydig cell nuclei. Expression of StAR and the steroidogenic enzymes cytochrome P450 side-chain cleavage enzyme (P450scc, CYP11A1) and cytochrome P450 17a-hydroxylase-17,20-lyase (P450c17, CYP17A1) in Leydig cells was blocked at the mRNA and protein level, showing no differences between the two agonists. Staining for androgen receptor (AR) by immunohistochemistry was positive in Sertoli, Leydig and peritubular cells and some spermatogonia, with in situ hybridization confirming expression in Sertoli cells. At the mRNA level, expression of AR was not affected; however, translation was blocked (reduced percentage of AR-positive Sertoli cells), with the number of nuclei in basal position being decreased. In the juvenile testes, mRNA expression of StAR, CYP11A1 and CYP17A1 was higher compared with the other groups but distinctly lower for the AR. At the protein level, the expression was at the limit of detection for StAR; AR-positive Sertoli cells were not detected. Our observations show that the down-regulated testis is different from the juvenile one rather resembling the testicular status in seasonal breeders out of season.
Introduction
Down-regulation of testicular function in the dog using slow-release gonadotrophin-releasing hormone (GNRH) agonist implants is now an accepted alternative approach to surgical castration. It covers all indications of surgical castration with the only difference being that down-regulation is in general a fully reversible effect (Vickery et al. 1984 , Dube et al. 1987a , 1987b , Riesenbeck et al. 2002 ). As we have shown previously ), down-regulation affects the whole steroidogenic cascade and leads to an arrest of spermatogenesis at the level of spermatogonia and primary spermatocytes . Clinical observations have clearly shown that duration of testicular down-regulation may considerably vary, e.g. between 3 months and O1 year (Goericke-Pesch et al. 2010b) . Presently, it can only be speculated whether this result from the degree of down-regulation at both the pituitary and testicular level or from the individual pharmacokinetic profile of the GNRH agonist.
The aim of the present paper was to assess the status of the canine testis at full down-regulation as indicated by having reached constant testosterone concentrations at around 0.1 ng/ml. Assessment was based on morphological evaluations and determination of the expression of the StAR and the steroidogenic enzymes cytochrome P450 side-chain cleavage enzyme (P450scc) and cytochrome P450 17a-hydroxylase-17,20-lyase (P450c17) after having applied two different GNRH agonist implants containing either azagly-nafarelin (Gonazon) or buserelin acetate (Profact Depot) as the active ingredient. Additionally, the expression of the androgen receptor (AR) as an indicator for hormonal responsiveness was examined. The same parameters were assessed in testis of juvenile dogs in order to establish likely differences to the down-regulated testis.
Materials and methods
Animal experimentation was approved by the respective authority (permit no. AZ V54-19c20/15c GI18/14, Regierungspräsidium Gießen).
Design of experiment, formation of groups
As described previously ), 35 sexually mature and clinically healthy male Beagle dogs had been implanted s.c. in the paraumbilical area with the removable GNRH agonist implant Gonazon, containing 18.5 mg azagly-nafarelin as the active ingredient (Intervet, Angers Technopole, France). Of this group, three dogs were randomly selected for this study and were castrated 5 months later after having achieved full down-regulation (testosterone, x g (DF)Z0.09 (1.0) ng/ml) forming group GG (Table 1) . Similarly, three dogs were implanted s.c. in the neck with the non-removable GNRH agonist implant Profact Depot (Sanofi-Aventis, Frankfurt Hoechst, Germany) containing 6.3 mg buserelin acetate forming group PG and were castrated again 5 months later with testosterone concentrations being the same as in group GG. Following castration, testes were preserved for further examinations as described previously ). Five adult male Beagle dogs (group CG) and three juvenile mixed breed males aged 2 months (group JG) served as untreated controls.
Tissue preservation
Collection and preservation of testicular tissue samples for immunohistochemistry (IHC) using Bouin's solution for fixation was as described previously ). For the preservation of tissue for RNA and protein extraction, parenchyma samples from the area between the tunica albuginea and the mediastinum testis were immersed in seven volumes of RNA later (Ambion Biotechnologie GmbH, Wiesbaden, Germany) for at least 24 h at 4 8C and then stored at K80 8C.
Morphological examinations
Sections (3-4 mm) from different paraffin blocks were cut, dried, haematoxylin-eosin stained and mounted in Histokitt (Assistent, Osterode, Germany). Based on previous observations (Goericke-Pesch et al. 2009), in groups GG and PG, tubuli (nZ200) were evaluated for the presence of spermatogonia only or spermatogonia and primary spermatocytes and the respective percentage was calculated. Area of Leydig cell nuclei was determined as described earlier ).
Slides stained for AR and evaluated as described below also served to determine the tubular area and the total number of Sertoli cells and spermatogonia per tubule. For evaluation of the tubular area, Leica Image Manager IM 1000 (Leica Microsystems, version 1.20, Wetzlar, Germany) measuring tool was used. The tubular area was determined according to the equation: areaZ 1 ⁄ 2 a! 1 ⁄ 2 b!p with a and b being the largest and smallest diameter in a right angle. The proportion (%) of the tubular compartment (TC), the interstitial compartment (IC) and the area of large vessels (AV) constituting the testicular parenchyma was obtained as described before when evaluating immunohistochemical staining for StAR, P450scc and P450c17 .
RT-PCR and semi-quantitative real-time PCR
The procedure including primers and probes for RT-PCR and semi-quantitative real-time PCR (qPCR) for StAR, CYP11A1 (P450SCC) and CYP17A1 (P450C17) was as described previously (Gentil 2012 . To test for the expression of the AR, the same procedure including treatment with DNase was applied for mRNA extraction and further preservation. For PCR of the AR, primer sets were developed using known sequences available from GenBank (Table 2) . PCR cycling conditions for AR were as follows: 95 8C for 10 min, followed by 35 cycles of 1 min at 94 8C, 2 min at 60 8C, 1.5 min at 72 8C and finally 72 8C for 10 min. In every experiment, DEPC-treated water was used instead of RNA as no-template control. Amplification of the reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as control for RNA integrity.
Primer and hydrolysis probe sequences used for qPCR of the AR as well as length of the amplicons are given in Table 2 . The master mix was prepared containing 25 ml iQ supermix for qPCR (2!; Bio-Rad Laboratories), 0.75 ml of the forward and reverse primer each (20 mM) and 0.5 ml TaqMan probe (20 mM) and 40 ml with DEPC-treated water. It was mixed with 10 ml cDNA of each sample. Afterwards, 23 ml were pipetted into a well of a MicroAmp Optical 96-Well Reaction Plate (Applied Biosystems). All samples were run in duplicates and a no-template control was included in every assay. The cycling conditions were as follows: 95 8C for 3 min, followed by 40 cycles of 15 s at 95 8C and 1 min at 60 8C. GAPDH was chosen as a reference gene for all qPCRs as it was shown to be non-regulated in preliminary and main experiments (data not shown). For evaluation of the qPCR results, an efficiencycorrected relative quantification according to Pfaffl (2001) was performed as described previously in detail .
The specificity of all primers used in RT-PCR and qPCR was checked using BLAST (http://blast.ncbi.nlm.nih.gov) and results were confirmed by sequencing of RT-PCR products (SRD GmbH, Bad Homburg, Germany). AR primers and probes were synthesized by Eurogentec S.A. (Seraing, Belgium); all other primers and probes were by Biomers.net GmbH (Ulm, Germany).
Protein extraction and western blot
The procedures for detection of StAR, CYP11A1 and CYP17A1 proteins have been described in detail and specificity of antisera was confirmed . Similar procedures were applied to test for the expression of the AR protein: pulverized frozen tissue (w100 mg) was dispersed with 
IHC and evaluation

StAR protein and steroidogenic enzymes
Evaluation was performed on ten images per dog. The procedure has been described in detail elsewhere ; briefly, the area of the TC and the AV was evaluated and subtracted from the total area, the resulting value corresponded to the area of the IC. Owing to the fact that all immunopositive signals were restricted to the Leydig cells, evaluation was performed via a computer-assisted image analysis using ImageTool 3.0, freeware (UTHSCSA, San Antonio, University of Texas, http:// ddsdx.uthscsa.edu/dig/itdesc.html). The parameters derived were the immunopositive staining area (IPSA) and the 'mean grey scale' as an indicator for the intensity of immunostaining. From the IC and the IPSA, the percentage of immunopositive interstitial area (PIA) was calculated . For all IHC procedures, negative controls were set up using irrelevant antibodies instead of the primary antibodies.
Androgen receptor
An immunoperoxidase method using the primary polyclonal AR antibody (AR(N-20): sc-816, Santa Cruz Biotechnology, Inc.) in a dilution of 1:10 000 was applied. A biotinylated polyclonal goat anti-rabbit Ig antibody (Vectastain ABC-Kit, Elite PK-6101 RABBIT IgG, Vector Laboratories, distributed by LINARIS GmbH) served as secondary antibody according to the manufacturer's instructions diluted in phosphate buffer with 1.4% BSA and 0.03% Triton X-100. The immunohistochemical staining procedure was according to Goericke-Pesch et al. (2009) with the following modifications: quenching of endogenous peroxidase was with 3% H 2 O 2 . Controls were incubated with the isotype-specific irrelevant serum 'Rabbit IgG' (Vector Laboratories, distributed by LINARIS GmbH) at an equal concentration. The colour reaction was initiated with the substrate (AEC substrate kit for peroxidase SK4200, Vector Laboratories, distributed by LINARIS GmbH) according to the manufacturer's instructions using Tris-HCl buffer instead of dest. water. Finally, the slides were washed under running tap water for 5 min, slightly counterstained with haematoxylin and mounted in Kaiser's glycerol gelatine (Merck).
In all animals, 20 seminiferous tubules were evaluated for the presence of staining and staining intensity at a 400-fold magnification. The total number of AR-positive and ARnegative Sertoli cells and spermatogonia was counted in each tubule and the location of AR-positive Sertoli cell nuclei in respect to the basal membrane was recorded. Results are expressed as % AR-positive spermatogonia and Sertoli cells, in case of the latter one making a distinction between the total percentage of positive Sertoli cells and positive Sertoli cells with nuclei in basal position. Additionally, 100 Leydig cells were checked for their staining.
AR and vimentin double staining
Double staining for AR and vimentin was performed to clearly differentiate between Sertoli cells and spermatogonia. The immunohistochemical procedure included antigen retrieval (washing with and cooking in citrate buffer, 3!5 min at 560 W in a microwave oven), blocking of endogenous peroxidases with 3% H 2 O 2 in methanol for 30 min and blocking of unspecific binding sites (35 min) with horse serum (10%) and goat serum according to the instructions of the manufacturer (Vectastain ABC-Kit, Elite PK-6101 RABBIT IgG, Vector Laboratories, distributed by LINARIS GmbH) in phosphate buffer with 1.4% BSA and 0.03% Triton X-100 (blocking buffer). Slides were incubated with the monoclonal mouse anti-vimentin antibody, clone V9 (Dako Cytomation Denmark A/S, Glostrup, Denmark; dilution 1:1000) or with the mouse IgG1 Ab-1 (clone NCG01, Dianova GmbH, Hamburg, Germany; dilution 1:870) as negative control for 1 h at 37 8C. Afterwards, they were incubated for 20 h at 4 8C with the other primary antibody (AR (N20): sc-816, Santa Cruz Biotechnology, Inc.; dilution 1:1000) or the respective rabbit IgG1 antibody as negative control, using the same protein concentration. Following another washing step using Tris-HCl buffer, both secondary antibodies, the alkaline phosphatase-conjugated horse anti-mouse IgG AP-2000 (Vector Laboratories, distributed by LINARIS GmbH; dilution 1:1000) and the HRP-conjugated goat anti-rabbit antibody (Vectastain ABC-Kit, Elite PK-6101 RABBIT IgG, Vector Laboratories, distributed by LINARIS GmbH; dilution according to the manufacturer's instruction, using blocking buffer as diluent), were pipetted onto the slides and incubated for 50 min at room temperature. For staining of vimentin, 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/nitroblue tetrazolium (NBT) (Roche Molecular Biochemicals) was used followed by staining of the AR by AEC (AEC substrate kit for peroxidase SK4200, Vector Laboratories, distributed by LINARIS GmbH). Finally, the slides were slightly counterstained with haematoxylin and mounted in Kaiser's glycerol gelatine (Merck).
In situ hybridization pGEM-T plasmid clone containing the insert for canine AR generated with the respective primers for RT-PCR was digested with the restriction enzymes NcoI (antisense cRNA) or NotI (sense cRNA) (New England Biolabs, Frankfurt, Germany) for cRNA synthesis using the Labeling Kit (SP6/T7) (Roche Diagnostics GmbH). cRNA was determined semiquantitatively by dot blot analysis of serial dilutions of DIG-labelled cRNA.
In situ hybridization (ISH) was performed on paraffinembedded sections of canine testes of all groups. Sections were mounted on Super-Frost-Plus slides (Menzel Glaeser, Braunschweig, Germany), dewaxed, digested with 20 mg/ml proteinase K (Boehringer, Mannheim, Germany) and postfixed with 4% paraformaldehyde and then processed according to the procedure by Lewis & Wells (1992) and Klonisch et al. (1999) . The DIG-labelled cRNA probes were detected by alkaline phosphatase-conjugated sheep anti-DIG Fab fragments (Boehringer) diluted 1:5000 in 1% ovine serum in washing buffer, as recommended by the supplier. The sections were incubated with the substrate BCIP in the presence of NBT (Roche Molecular Biochemicals) yielding a dark blue precipitate at the site of the label.
Statistical analysis
For normally distributed data, the arithmetic mean and S.D.
(xGS.D.) are given. In case of an uneven distribution, logarithmic transformation of data was applied and data are presented as geometric mean and dispersion factor (x g (DF)). In case of uneven distribution with logarithmical transformation not resulting in a normal distribution, data were presented as median and first and third quartile (x (Q1/Q3)). As PIA was expressed in percentage with a skewed distribution to the right, data were arc sine transformed to get an approximately normal distribution. Mean values and S.D. of these arc sine transformed data were calculated and the data retransformed, yielding the modified mean (x r ) and 1 S.D. range (Sachs 1982 , Sheskin 2007 ).
To test for the effect of group, a one-way ANOVA was applied in case of normally distributed data, followed by the Tukey-Kramer paired comparison test in case the results of 
Results
Area of interstitial and TC
There was a significant effect of group for all parameters assessed (Table 3) . Tubule area (mm 2 ) was larger (P!0.01) in CG compared with GG, PG and JG, which were not different (Table 3 , Fig. 1, white bar) . The percent relationship between the three testicular compartments evaluated (TC, IC and AV) showed that the percentage of TC was significantly higher in GG and PG compared with JG (P!0.01) but lower than in CG (P!0.01); GG and PG were not different. The percentage of IC was higher in GG and PG compared with CG (P!0.05) but lower than in JG (P!0.01). The percentage of AV was higher in GG and PG compared with CG (P!0.01), with a higher value obtained for PG compared with JG (P!0.01) ( Table 3) .
Area of Leydig cell nuclei
The area of Leydig cell nuclei revealed a significant effect of group with nuclei being significantly smaller in GG and PG than in JG and CG (P!0.01) and being larger in CG than in JG (P!0.01) ( Table 3 , Fig. 1, grey bar) .
Number of spermatogonia and Sertoli cells per tubule
There was a significant effect of group for both parameters and number of spermatogonia was lower in GG (P!0.05) and PG (P!0.01) compared with CG (Table 3) . Spermatogonia had not yet developed and only gonocytes were observed in JG. Number of Sertoli cells was highest in JG (P!0.05) with no difference between GG, PG and CG.
Tubules with spermatogonia and primary spermatocytes
In group GG, 39.1G7.9% of the tubules showed spermatogonia and primary spermatocytes, the respective figure for PG was 35.5G28.4%; there was no statistically significant difference.
Expression of StAR
At the mRNA level, expression of StAR showed a significant effect of group with the ratio being significantly higher (P!0.05) in JG compared with the other groups, which were not different, apart from a tendency of a higher value in CG (Table 4 , Fig. 2) .
Positive immunostaining was restricted to Leydig cells (Fig. 3 ). There was a significant effect of group for PIA; no or only very few Leydig cells were stained in GG, PG and JG when compared with CG (Table 4 , P!0.01). There was no significant effect of group concerning the mean greyscale values, although there was a tendency of a somewhat lower value in PG compared with CG (Table 4 , Fig. 4 ). 
Steroidogenic enzymes
Expression of CYP11A1
Immunostaining was restricted to Leydig cells (Fig. 3 ).
There was a significant effect of group for all parameters assessed (Table 4 , Figs 2 and 4) . Expression of the mRNA (ratio) was highest in JG, followed by CG; however, a pairwise comparison yielded no differences (Table 4 , Fig. 2 ). Mean greyscale values were higher in CG when compared with GG and PG (P!0.05) but not different to JG, which did not differ from GG and PG (Table 4 , Fig. 4 ). Regarding PIA, almost no Leydig cells were stained in GG and PG with PIA being significantly lower compared with CG (P!0.01) and JG (P!0.05); JG and CG were not significantly different, but mean PIA of CG was about twofold higher than that of JG (Table 4) .
Expression of CYP17A1
Only Leydig cells stained positive (Fig. 3 ). There was a significant effect of group for all parameters assessed (Table 4 , Figs 2 and 4). Relative gene expression (ratio) was higher in JG than in the other groups (P!0.01), which were not different, apart from a tendency of a higher value in CG (Table 4 , Fig. 2 ). The mean greyscale value was highest in CG and different from PG (P!0.05) with GG and JG not being different from either side (Table 4 , Fig. 4) . PIA was significantly (P!0.01) higher in CG compared with the other groups; however, there was a clear tendency for a higher PIA in JG compared with PG and GG (Table 4) .
Androgen receptor
Western blot showed a specific protein band at about 110 kDa in canine and murine testicular protein extracts (Fig. 5) . When applying IHC, apart from Sertoli cells also Leydig cells, peritubular myoid cells, some spermatogonia ( Fig. 6 ) and pericytes (not shown) stained positive for the AR; identity of spermatogonia was verified by double staining (Fig. 7 ).
There was a significant effect of group for the three parameters presented in Table 5 . Relative gene expression (ratio) was significantly (P!0.01) lower in JG compared with the other groups (Fig. 2) . Concerning Sertoli cells, virtually all cells were stained in CG, none of them were stained in JG and in two dogs of group PG while 93.9% were stained in the third dog of this group. Also in GG, staining was highly variable (0, 16.7 and 98.1%) and consequently the distinctly lower median values were not different from PG, CG and JG. Virtually all AR-positive Sertoli cell nuclei were located at the basal membrane in CG, while in the other groups only up to 0.84% (GG) positive Sertoli cell nuclei were located at the same position; again, the differences between CG and JG were highly significant with both groups not being different from GG and PG.
As no spermatogonia were yet developed in JG, data for AR-positive spermatogonia only refer to GG, PG and CG (data given as median (first/third quartile); GG 19.33% (9.66/27.49%), PG 3.49% (1.74/12.16%) and CG 12.65% (5.66/14.94%)). There was no significant effect of group. Similarly, no differences were observed concerning staining of Leydig cells for the AR (data given as median (first/third quartile); GG 13% (12/40.5%), PG 4% (4/33.5%), JG 56% (54.5/62.5%) and CG 69% (49/90%)). When applying ISH and different to IHC, the only positive cells clearly identified were Sertoli cells (Fig. 8) .
Discussion
Down-regulation affects the whole steroidogenic pathway including the StAR protein, at both, the mRNA and protein level leading to an arrest of spermatogenesis at the level of spermatogonia and spermatocytes as was reported earlier . The present data clearly show that basically the same state of testicular down-regulation is achieved 5 months after treatment when using GNRH agonist implants with different active ingredients (azagly-nafarelin vs buserelin acetate).
Thus, the high variation observed in the duration of clinical efficacy (Riesenbeck et al. 2002 , Goericke-Pesch et al. 2010a , 2010b ) not so much seems to be a matter of the degree of testicular down-regulation but rather a matter of the pharmacokinetic profile and an individual reaction towards the implant. However, as there are no data on the restoration of pituitary GNRH receptors, a protracted restoration irrespectively of a ceased GNRH release from the drug applied may also be assumed.
In the down-regulated testis and when compared with CG, the percentage of the TC area is significantly decreased while the percentage of the IC area is increased. This situation is seen in seasonal breeders like the roe deer or the Djungarian hamster where luteinizing hormone, follicle-stimulating hormone and testosterone are basal out of season (Barth et al. 1976 , Schams & Barth 1982 , Sempere et al. 1998 , Roelants et al. 2002 with spermatogenesis being arrested at the level of spermatogonia (Bergmann 1987 , Blottner et al. 1996 , Goeritz et al. 2003 , Schö n et al. 2004 resulting in a significantly reduced tubular diameter (Schön et al. 2004 ) and consequently testicular mass. As previously observed , also the area of the Leydig cell nuclei is reduced. A similar observation was made in the Djungarian hamster (Bergmann 1987) and the billy goat (Leidl et al. 1970 ) when out of season, pointing towards a loss of or reduced steroidogenic activity. The movement of Sertoli cell nuclei from a more basal to a more luminal position in the down-regulated testis as seen in this study is characteristic for seasonal breeding animals, too (Schö n et al. 2004) .
As seasonal up-regulation of testicular function is a process occurring regularly in periodic intervals resulting in full fertility, it can be expected that the same situation applies to the down-regulated testis. The few observations made after repetitive treatments with a GNRH agonist implant (Riesenbeck et al. 2002 , Goericke-Pesch et al. 2010a seem to confirm this conclusion. However, further confirmation is necessary.
In the down-regulated testis, the loss of steroidogenic capacity is well demonstrated at the protein level with PIA being significantly lower in GG and PG when compared with CG. Also mRNA expression of StAR, CYP11A1 and CYP17A1 was obviously reduced in GG and PG when compared with CG, with the pairwise comparison, however, showing no statistically significant difference; yet, due to small group size, statistical analysis must be considered less strong.
Other than that in the juvenile testis, the steroidogenic apparatus (StAR protein, CYP11A1 and CYP17A1) is highly expressed at the mRNA level, even exceeding the values observed in CG. As indicated by PIA, also expression at the protein level is not different from CG for CYP11A1. Different to that, expression of StAR and CYP17A1 as indicated by PIA is distinctly lower in JG and not different from GG and PG. This observation suggests that provision of StAR seems to be regulated at the posttranscriptional level in the juvenile testis. As there were hardly any differences in mean (Walker 2009 , 2011 , Wang et al. 2009 , Fietz et al. 2011 . However, as both positive (Galena et al. 1974 , Grootegoed et al. 1977 , Warikoo et al. 1986 , Kimura et al. 1993 , Bremner et al. 1994 , Janssen et al. 1994 , Vornberger et al. 1994 , Van Roijen et al. 1995 , Zhou et al. 1996 , Suarez-Quian et al. 1999 , Pelletier et al. 2000 , Arenas et al. 2001 , Solakidi et al. 2005 , Aquila et al. 2007 , Merlet et al. 2007 ) and negative observations (Galena et al. 1974 , Bremner et al. 1994 , Van Roijen et al. 1995 , Suarez-Quian et al. 1999 , Pelletier et al. 2000 were made concerning the expression of the AR in germ cells, it cannot be ruled out that staining was due to interactions of the antibody with other proteins than the AR. Thus, the further discussion on the AR only accounts for the respective PCR data and its expression in Sertoli cells.
Clearly, expression of the AR at the mRNA level is not reduced. However, the percentage of AR-positive Sertoli cell nuclei in GG and PG is significantly reduced. This may indicate that, at least in Sertoli cells, downregulation affects AR expression at the posttranscriptional level. The still high expression of AR mRNA points to the 'readiness' of Sertoli cells to a quick up-regulation of full function following abolishment of downregulation. This is in good agreement with our earlier observations that testicular function is quickly up-regulated when the GNRH agonist implant was removed .
Our study also clearly indicates that there is little if any expression of the AR in JG, yielding the testis insensitive to a direct effect of androgens. Clearly, this situation must be overcome during the course of puberty as was shown for other species (Bremner et al. 1994 , McKinnell et al. 2001 .
Conclusion
In conclusion, immunostaining for StAR, CYP11A1 and CYP17A1 was restricted to Leydig cells; positive staining for the AR was observed in Sertoli cells, Leydig cells, peritubular cells and some spermatogonia. However, ISH only confirmed expression in the Sertoli cells calling for further investigations. Treatment with a slow-release GNRH agonist implant blocked the steroidogenic apparatus showing no differences between the two agonists; mRNA expression of the AR was not affected; however, translation was blocked. Thus, in contrast to StAR, CYP11A1 and CYP17A1, which are most likely regulated at the mRNA level, expression of the AR is affected at the posttranscriptional level. In JG, mRNA expression of StAR, CYP11A1 and CYP17A1 was higher compared with the other groups but distinctly lower for the AR. Expression at the protein level was at the limit of detection for StAR; AR-positive Sertoli cells were not detected in JG. Thus, in the juvenile testis, the steroidogenic apparatus is highly expressed at the Different superscript letters indicate significant differences between groups (P!0.01-!0.05).
524 S Goericke-Pesch and others mRNA level, but not at the protein level, again pointing to posttranscriptional regulatory mechanisms. These observations show that the down-regulated testis is different from the juvenile one rather resembling the testicular status in seasonal breeders out of season.
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